Policlinico Umberto I - Academic Profile

Publications

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Marc Humbert , Gábor Kovács , Marius M. Hoeper +26 more

Guidelines summarize and evaluate available evidence, with the aim of assisting health professionals in proposing the best management strategies for an individual patient with a...

2022 European Respiratory Journal 1728 citations

The Human Toll Signaling Pathway: Divergence of Nuclear Factor κB and JNK/SAPK Activation Upstream of Tumor Necrosis Factor Receptor–associated Factor 6 (TRAF6)

Marta Muzio , Gioacchino Natoli , Simona Saccani +2 more

The human homologue of Drosophila Toll (hToll) is a recently cloned receptor of the interleukin 1 receptor (IL-1R) superfamily, and has been implicated in the activation of adap...

1998 The Journal of Experimental Medicine 571 citations

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

Marina Chiara Garassino , Olga Martelli , Massimo Broggini +17 more

2013 The Lancet Oncology 475 citations

Affiliated Researchers

Institution Info

Type: healthcare
Country: IT
Publications: 3
Citations: 2,774

External Links

Identifiers

ROR: https://ror.org/011cabk38

Publications

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

The Human Toll Signaling Pathway: Divergence of Nuclear Factor κB and JNK/SAPK Activation Upstream of Tumor Necrosis Factor Receptor–associated Factor 6 (TRAF6)

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

Affiliated Researchers

Flavia Longo

Simona Saccani

Massimo Levrero

Roberto Badagliacca

Institution Info

External Links

Identifiers